U.S. Stem Cell, Inc. (USRM)

U.S. Stem Cell, Inc. (OTC:USRM) is an emerging leader in the worldwide development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Based in Sunrise, Florida, the Company has developed a clinical protocol and kit - AdipoCellTM - that helps isolate a patient`s own stem cells while keeping them intact, in order to harness their healing ability for a wide variety of indications. USRM also trains and certifies physicians from around the world in the administration of stem cell therapies and protocols - to date, more than 700+ physicians worldwide. The company is also in the process of opening standalone and partnered stem cell clinics - to date, four in the United States - and several worldwide.